Conservatism, Consumer Choice and the Food and Drug Administration during the Reagan era: a Prescription for Scandal

Lucas Richert

Research output: Book/ReportBook


In the last quarter of the 20th century, politicians in Washington, as well as interest groups, regulatory policy makers, and drug industry leaders were forced to confront the hot-button issue of pharmaceutical regulation. The struggle always centered on product innovation, consumer protection, and choice in the free market. As the American economy stuttered in the late 1970s, the stakes were extremely high for the powerful drug industry and the American public. At the center of this drama was the Food and Drug Administration, which was censured from both the left and right of the political spectrum for being too strict and too lenient in the application of its regulatory powers.
Original languageEnglish
Place of PublicationLanham, MD.
Number of pages260
Publication statusPublished - 22 May 2014


  • United States
  • Food and Drug Administration
  • pharmaceutical policy
  • drug development
  • consumer protection

Cite this